Nucleotide analogs
First Claim
1. A nucleotide analog comprising a detectable label attached to the nitrogenous base portion of the nucleotide by a cleavable linker,wherein contact of the analog with a reducing agent results in release of the label and elimination of the linker, thereby producing a natural nucleotide, 9-deaza-G, 9-deaza-A, or ψ
- -uridine, characterized in that no portion of the label or the linker remains attached to the nitrogenous base after cleavage.
9 Assignments
0 Petitions
Accused Products
Abstract
The invention generally relates to nucleotide analogs and methods of their use in sequencing-by-synthesis reactions. In certain embodiments, the invention provides a nucleotide analog including a detectable label attached to a nitrogenous base portion of a nucleotide analog by a cleavable linker, in which contact of the analog with at least one activating agent results in cleavage of the label and elimination of the linker, thereby producing a natural nucleotide, a 9-deaza-G, 9-deaza-A, or ψ-uridine.
32 Citations
38 Claims
-
1. A nucleotide analog comprising a detectable label attached to the nitrogenous base portion of the nucleotide by a cleavable linker,
wherein contact of the analog with a reducing agent results in release of the label and elimination of the linker, thereby producing a natural nucleotide, 9-deaza-G, 9-deaza-A, or ψ - -uridine, characterized in that no portion of the label or the linker remains attached to the nitrogenous base after cleavage.
- View Dependent Claims (2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38)
-
13. A nucleotide analog comprising a structure selected from:
Specification